• Good to see inventory and debtor days coming down in the current year.
Inventory days have come down from 216 to 192 and debtor days from 97 to 82
• Cash at 715 crores before payment for the acquisition of Teva facility.
• In addition to buyback company redeemed 7 % preference shares in the last FY.
• Good pipeline for launch of products
• Integration of Teva facility will be a key thing to watch out for. 56 crores spent for the acquisition of plant. Expecting the facility to break even on net profit level by Q3.
• EBITDA margin improvement was mainly due to freight rate reduction. Most of the high cost inventory is over.
Source: concall transcript
Subscribe To Our Free Newsletter |